

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 5.80796561 |
| 2 | viral transcription (GO:0019083) | 5.02978883 |
| 3 | translational termination (GO:0006415) | 4.82698736 |
| 4 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.72230123 |
| 5 | cotranslational protein targeting to membrane (GO:0006613) | 4.69715849 |
| 6 | protein targeting to ER (GO:0045047) | 4.62470370 |
| 7 | ribosomal small subunit biogenesis (GO:0042274) | 4.51400623 |
| 8 | protein localization to endoplasmic reticulum (GO:0070972) | 4.41663230 |
| 9 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.39157712 |
| 10 | translational elongation (GO:0006414) | 4.04569935 |
| 11 | detection of molecule of bacterial origin (GO:0032490) | 4.00613277 |
| 12 | DNA deamination (GO:0045006) | 3.99505566 |
| 13 | viral life cycle (GO:0019058) | 3.86701345 |
| 14 | negative regulation of interleukin-12 production (GO:0032695) | 3.84192812 |
| 15 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.82175940 |
| 16 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.82175940 |
| 17 | modulation by symbiont of host immune response (GO:0052553) | 3.82175940 |
| 18 | positive regulation by symbiont of host defense response (GO:0052509) | 3.82175940 |
| 19 | modulation by symbiont of host defense response (GO:0052031) | 3.82175940 |
| 20 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.82175940 |
| 21 | cellular protein complex disassembly (GO:0043624) | 3.80253749 |
| 22 | neutrophil activation involved in immune response (GO:0002283) | 3.64544024 |
| 23 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.58357416 |
| 24 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.57192566 |
| 25 | macrophage activation involved in immune response (GO:0002281) | 3.52243548 |
| 26 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.50501430 |
| 27 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.48533019 |
| 28 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.46965826 |
| 29 | translational initiation (GO:0006413) | 3.40234605 |
| 30 | signal peptide processing (GO:0006465) | 3.36647199 |
| 31 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.33629909 |
| 32 | granulocyte activation (GO:0036230) | 3.29194296 |
| 33 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.28546477 |
| 34 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.25813547 |
| 35 | ATP synthesis coupled proton transport (GO:0015986) | 3.25633551 |
| 36 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.25633551 |
| 37 | response to interferon-beta (GO:0035456) | 3.25390294 |
| 38 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.23424415 |
| 39 | platelet dense granule organization (GO:0060155) | 3.23291076 |
| 40 | cellular response to interferon-beta (GO:0035458) | 3.17735583 |
| 41 | chaperone-mediated protein transport (GO:0072321) | 3.16978889 |
| 42 | sequestering of actin monomers (GO:0042989) | 3.16296958 |
| 43 | protein targeting to membrane (GO:0006612) | 3.16060539 |
| 44 | protein complex disassembly (GO:0043241) | 3.15486248 |
| 45 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.15437856 |
| 46 | response to host immune response (GO:0052572) | 3.15437856 |
| 47 | proteasome assembly (GO:0043248) | 3.14711206 |
| 48 | maturation of SSU-rRNA (GO:0030490) | 3.12955395 |
| 49 | detection of external biotic stimulus (GO:0098581) | 3.11026978 |
| 50 | translation (GO:0006412) | 3.10655095 |
| 51 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.09720495 |
| 52 | phagosome maturation (GO:0090382) | 3.09515142 |
| 53 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.07339232 |
| 54 | macrophage activation (GO:0042116) | 3.03744093 |
| 55 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.03293788 |
| 56 | detection of other organism (GO:0098543) | 3.02750772 |
| 57 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.01300028 |
| 58 | macromolecular complex disassembly (GO:0032984) | 2.99825336 |
| 59 | mast cell activation (GO:0045576) | 2.99504173 |
| 60 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.97793237 |
| 61 | negative regulation of phagocytosis (GO:0050765) | 2.97434886 |
| 62 | regulation of podosome assembly (GO:0071801) | 2.97249012 |
| 63 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.96366426 |
| 64 | ribosomal large subunit biogenesis (GO:0042273) | 2.95584525 |
| 65 | protein neddylation (GO:0045116) | 2.94937416 |
| 66 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.91834362 |
| 67 | respiratory burst (GO:0045730) | 2.89932040 |
| 68 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.89245265 |
| 69 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.89245265 |
| 70 | NADH dehydrogenase complex assembly (GO:0010257) | 2.89245265 |
| 71 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.88571994 |
| 72 | termination of RNA polymerase III transcription (GO:0006386) | 2.88571994 |
| 73 | respiratory chain complex IV assembly (GO:0008535) | 2.86126603 |
| 74 | microglial cell activation (GO:0001774) | 2.85023366 |
| 75 | oligosaccharide catabolic process (GO:0009313) | 2.84444697 |
| 76 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.82530989 |
| 77 | purine nucleotide salvage (GO:0032261) | 2.82126407 |
| 78 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.82095274 |
| 79 | protein complex biogenesis (GO:0070271) | 2.81448980 |
| 80 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.80155449 |
| 81 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.78563554 |
| 82 | negative regulation of ligase activity (GO:0051352) | 2.78563554 |
| 83 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.77643960 |
| 84 | response to host (GO:0075136) | 2.77643960 |
| 85 | response to host defenses (GO:0052200) | 2.77643960 |
| 86 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.74610497 |
| 87 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.74610497 |
| 88 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.74572177 |
| 89 | GTP biosynthetic process (GO:0006183) | 2.73950531 |
| 90 | telomere maintenance via recombination (GO:0000722) | 2.73033049 |
| 91 | cytochrome complex assembly (GO:0017004) | 2.71994676 |
| 92 | B cell mediated immunity (GO:0019724) | 2.71460786 |
| 93 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.70131768 |
| 94 | detection of biotic stimulus (GO:0009595) | 2.70019545 |
| 95 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.69395060 |
| 96 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.69338923 |
| 97 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.69338923 |
| 98 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.69338923 |
| 99 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.67373142 |
| 100 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.67131320 |
| 101 | myeloid cell activation involved in immune response (GO:0002275) | 2.66390022 |
| 102 | respiratory electron transport chain (GO:0022904) | 2.65451342 |
| 103 | regulation of B cell differentiation (GO:0045577) | 2.65096998 |
| 104 | regulation of protein heterodimerization activity (GO:0043497) | 2.62609932 |
| 105 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.60354207 |
| 106 | regulation of interferon-alpha production (GO:0032647) | 2.60058124 |
| 107 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.59873026 |
| 108 | leukocyte aggregation (GO:0070486) | 2.59696585 |
| 109 | defense response to protozoan (GO:0042832) | 2.59031298 |
| 110 | negative regulation of interleukin-17 production (GO:0032700) | 2.58144831 |
| 111 | electron transport chain (GO:0022900) | 2.57489461 |
| 112 | response to peptidoglycan (GO:0032494) | 2.57284654 |
| 113 | positive regulation of mast cell degranulation (GO:0043306) | 2.57151849 |
| 114 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.57151849 |
| 115 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.56783997 |
| 116 | lymphoid progenitor cell differentiation (GO:0002320) | 2.56151893 |
| 117 | detection of bacterium (GO:0016045) | 2.55716764 |
| 118 | cellular response to zinc ion (GO:0071294) | 2.55384316 |
| 119 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.53228663 |
| 120 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.52544881 |
| 121 | positive regulation of B cell differentiation (GO:0045579) | 2.52115212 |
| 122 | chronic inflammatory response (GO:0002544) | 2.51871719 |
| 123 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.51521292 |
| 124 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.51521292 |
| 125 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.51273051 |
| 126 | protein maturation by protein folding (GO:0022417) | 2.50122590 |
| 127 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.49854943 |
| 128 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.49819830 |
| 129 | phagocytosis, engulfment (GO:0006911) | 2.49741944 |
| 130 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.48066775 |
| 131 | positive regulation of interferon-alpha production (GO:0032727) | 2.47561651 |
| 132 | positive regulation of mast cell activation (GO:0033005) | 2.47519021 |
| 133 | positive regulation of interleukin-6 production (GO:0032755) | 2.47362925 |
| 134 | T-helper 1 type immune response (GO:0042088) | 2.46897832 |
| 135 | regulation of mononuclear cell migration (GO:0071675) | 2.46876321 |
| 136 | histamine secretion (GO:0001821) | 2.46353656 |
| 137 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.46334356 |
| 138 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.46163991 |
| 139 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.45847668 |
| 140 | negative regulation of cell killing (GO:0031342) | 2.45847668 |
| 141 | myeloid dendritic cell activation (GO:0001773) | 2.45747477 |
| 142 | cellular extravasation (GO:0045123) | 2.45561535 |
| 143 | positive regulation of ligase activity (GO:0051351) | 2.45282810 |
| 144 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.45224417 |
| 145 | DNA strand elongation (GO:0022616) | 2.44827569 |
| 146 | mRNA catabolic process (GO:0006402) | 2.44565905 |
| 147 | immunoglobulin mediated immune response (GO:0016064) | 2.43837858 |
| 148 | mannosylation (GO:0097502) | 2.42854556 |
| 149 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.42532005 |
| 150 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.42196089 |
| 151 | regulation of oxidative phosphorylation (GO:0002082) | 2.41011019 |
| 152 | regulation of mast cell degranulation (GO:0043304) | 2.40471009 |
| 153 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.40286881 |
| 154 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.40164679 |
| 155 | establishment of integrated proviral latency (GO:0075713) | 2.40078499 |
| 156 | nucleoside salvage (GO:0043174) | 2.39654481 |
| 157 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.39413232 |
| 158 | mitotic recombination (GO:0006312) | 2.39100817 |
| 159 | positive regulation of actin filament depolymerization (GO:0030836) | 2.38867131 |
| 160 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.38815034 |
| 161 | establishment of viral latency (GO:0019043) | 2.37288636 |
| 162 | response to protozoan (GO:0001562) | 2.37235042 |
| 163 | purine-containing compound salvage (GO:0043101) | 2.37185131 |
| 164 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.36977024 |
| 165 | positive regulation of leukocyte degranulation (GO:0043302) | 2.36745711 |
| 166 | neutrophil activation (GO:0042119) | 2.34064082 |
| 167 | actin nucleation (GO:0045010) | 2.33441507 |
| 168 | B cell receptor signaling pathway (GO:0050853) | 2.32462145 |
| 169 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.32367448 |
| 170 | CTP metabolic process (GO:0046036) | 2.32018833 |
| 171 | CTP biosynthetic process (GO:0006241) | 2.32018833 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 5.24641442 |
| 2 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.71541584 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.69511385 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.25675775 |
| 5 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.17047410 |
| 6 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.16048628 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.12580044 |
| 8 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.11128821 |
| 9 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.06128403 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.02615346 |
| 11 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.95700540 |
| 12 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.87903506 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.87541112 |
| 14 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.76844286 |
| 15 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.65232952 |
| 16 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.63557701 |
| 17 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.60409031 |
| 18 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.57020971 |
| 19 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.50745931 |
| 20 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.50008327 |
| 21 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.47402086 |
| 22 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.43858274 |
| 23 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.32769110 |
| 24 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.31471584 |
| 25 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.29612808 |
| 26 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.26122069 |
| 27 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.25079617 |
| 28 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.22097611 |
| 29 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.16907866 |
| 30 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.12430100 |
| 31 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.08446730 |
| 32 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.07583298 |
| 33 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.07364446 |
| 34 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.06800580 |
| 35 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.03305222 |
| 36 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.01972619 |
| 37 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.98190548 |
| 38 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.92591858 |
| 39 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.85045271 |
| 40 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.84740178 |
| 41 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.82650599 |
| 42 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.82321047 |
| 43 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82059408 |
| 44 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.80075934 |
| 45 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.79386339 |
| 46 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.76647392 |
| 47 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.74914753 |
| 48 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.71165419 |
| 49 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.66719784 |
| 50 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60481949 |
| 51 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.60009078 |
| 52 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.59449330 |
| 53 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.58801495 |
| 54 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.56894469 |
| 55 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.56741997 |
| 56 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53011872 |
| 57 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.50421002 |
| 58 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.47690856 |
| 59 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.45820463 |
| 60 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.44068833 |
| 61 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.43560454 |
| 62 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.41951903 |
| 63 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.41651820 |
| 64 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.40390625 |
| 65 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.39754191 |
| 66 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.38893085 |
| 67 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.38325676 |
| 68 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.38222377 |
| 69 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.37765844 |
| 70 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.37205851 |
| 71 | MYB_26560356_Chip-Seq_TH2_Human | 1.36609637 |
| 72 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.35571215 |
| 73 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.34732677 |
| 74 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.33887698 |
| 75 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.33631788 |
| 76 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.28605812 |
| 77 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.28098968 |
| 78 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.25294046 |
| 79 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.24265060 |
| 80 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22816979 |
| 81 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.20866186 |
| 82 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.19607622 |
| 83 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.19401372 |
| 84 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.18824115 |
| 85 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.18610171 |
| 86 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.14619701 |
| 87 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14388572 |
| 88 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.13734286 |
| 89 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.13484812 |
| 90 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.13203303 |
| 91 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11822774 |
| 92 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.10115057 |
| 93 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.10024141 |
| 94 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.08919872 |
| 95 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.06408118 |
| 96 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.05487990 |
| 97 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05185791 |
| 98 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.04693240 |
| 99 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.04007177 |
| 100 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03988997 |
| 101 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.03813947 |
| 102 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.01989232 |
| 103 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00618298 |
| 104 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99434178 |
| 105 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.97549642 |
| 106 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.97364648 |
| 107 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.97028930 |
| 108 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.95870153 |
| 109 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94432719 |
| 110 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.93287681 |
| 111 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.92682264 |
| 112 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.92665794 |
| 113 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92237921 |
| 114 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.91737680 |
| 115 | GATA1_22025678_ChIP-Seq_K562_Human | 0.91668821 |
| 116 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.91317573 |
| 117 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.90296885 |
| 118 | GATA3_26560356_Chip-Seq_TH2_Human | 0.90111018 |
| 119 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.89978506 |
| 120 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.89857277 |
| 121 | EWS_26573619_Chip-Seq_HEK293_Human | 0.88778879 |
| 122 | SPI1_23127762_ChIP-Seq_K562_Human | 0.88719065 |
| 123 | MYB_26560356_Chip-Seq_TH1_Human | 0.88718141 |
| 124 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.87996852 |
| 125 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.87543895 |
| 126 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87524728 |
| 127 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.87116997 |
| 128 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.85976377 |
| 129 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.85915854 |
| 130 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.84692281 |
| 131 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.84456212 |
| 132 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.81488710 |
| 133 | MAF_26560356_Chip-Seq_TH1_Human | 0.81390168 |
| 134 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.81272768 |
| 135 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.81158849 |
| 136 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.78548114 |
| 137 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.77451738 |
| 138 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.76639669 |
| 139 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.76572942 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.30519336 |
| 2 | MP0003806_abnormal_nucleotide_metabolis | 4.15185749 |
| 3 | MP0002148_abnormal_hypersensitivity_rea | 3.11737184 |
| 4 | MP0009379_abnormal_foot_pigmentation | 3.03748457 |
| 5 | MP0009785_altered_susceptibility_to | 2.98867907 |
| 6 | MP0005671_abnormal_response_to | 2.84180667 |
| 7 | MP0003191_abnormal_cellular_cholesterol | 2.81311168 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.66825572 |
| 9 | MP0005025_abnormal_response_to | 2.42984805 |
| 10 | MP0003724_increased_susceptibility_to | 2.39948196 |
| 11 | MP0002419_abnormal_innate_immunity | 2.38787726 |
| 12 | MP0002396_abnormal_hematopoietic_system | 2.35349803 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.34814921 |
| 14 | MP0002420_abnormal_adaptive_immunity | 2.27096053 |
| 15 | MP0001819_abnormal_immune_cell | 2.25627004 |
| 16 | MP0003436_decreased_susceptibility_to | 2.25613904 |
| 17 | MP0000685_abnormal_immune_system | 2.24937021 |
| 18 | MP0001800_abnormal_humoral_immune | 2.23064582 |
| 19 | MP0002723_abnormal_immune_serum | 2.19848075 |
| 20 | MP0009333_abnormal_splenocyte_physiolog | 2.18143385 |
| 21 | MP0001853_heart_inflammation | 2.18122469 |
| 22 | MP0008438_abnormal_cutaneous_collagen | 2.04448906 |
| 23 | MP0000015_abnormal_ear_pigmentation | 2.02986379 |
| 24 | MP0005451_abnormal_body_composition | 2.01707810 |
| 25 | MP0002277_abnormal_respiratory_mucosa | 2.00790739 |
| 26 | MP0001790_abnormal_immune_system | 2.00199419 |
| 27 | MP0005387_immune_system_phenotype | 2.00199419 |
| 28 | MP0008004_abnormal_stomach_pH | 1.94011680 |
| 29 | MP0003195_calcinosis | 1.91477819 |
| 30 | MP0005174_abnormal_tail_pigmentation | 1.90581588 |
| 31 | MP0002398_abnormal_bone_marrow | 1.89517068 |
| 32 | MP0006082_CNS_inflammation | 1.88582823 |
| 33 | MP0003763_abnormal_thymus_physiology | 1.80871137 |
| 34 | MP0005503_abnormal_tendon_morphology | 1.78547458 |
| 35 | MP0000716_abnormal_immune_system | 1.76788618 |
| 36 | MP0002139_abnormal_hepatobiliary_system | 1.72722897 |
| 37 | MP0008260_abnormal_autophagy | 1.69658971 |
| 38 | MP0002095_abnormal_skin_pigmentation | 1.66984478 |
| 39 | MP0006054_spinal_hemorrhage | 1.63750724 |
| 40 | MP0002405_respiratory_system_inflammati | 1.62791964 |
| 41 | MP0003300_gastrointestinal_ulcer | 1.61725708 |
| 42 | MP0002933_joint_inflammation | 1.60948047 |
| 43 | MP0001905_abnormal_dopamine_level | 1.59219933 |
| 44 | MP0000372_irregular_coat_pigmentation | 1.56710696 |
| 45 | MP0003303_peritoneal_inflammation | 1.56212027 |
| 46 | MP0000858_altered_metastatic_potential | 1.51908739 |
| 47 | MP0000689_abnormal_spleen_morphology | 1.50431147 |
| 48 | MP0001533_abnormal_skeleton_physiology | 1.50314785 |
| 49 | MP0004808_abnormal_hematopoietic_stem | 1.49977876 |
| 50 | MP0005166_decreased_susceptibility_to | 1.49782563 |
| 51 | MP0002429_abnormal_blood_cell | 1.49683611 |
| 52 | MP0005464_abnormal_platelet_physiology | 1.48029048 |
| 53 | MP0002006_tumorigenesis | 1.45631386 |
| 54 | MP0002877_abnormal_melanocyte_morpholog | 1.45009938 |
| 55 | MP0002722_abnormal_immune_system | 1.41064854 |
| 56 | MP0002166_altered_tumor_susceptibility | 1.40575555 |
| 57 | MP0002254_reproductive_system_inflammat | 1.40313618 |
| 58 | MP0003828_pulmonary_edema | 1.39568730 |
| 59 | MP0003880_abnormal_central_pattern | 1.39342278 |
| 60 | MP0006036_abnormal_mitochondrial_physio | 1.36300953 |
| 61 | MP0001188_hyperpigmentation | 1.34715981 |
| 62 | MP0000343_altered_response_to | 1.33944628 |
| 63 | MP0001845_abnormal_inflammatory_respons | 1.33315209 |
| 64 | MP0003279_aneurysm | 1.32118856 |
| 65 | MP0000465_gastrointestinal_hemorrhage | 1.27292037 |
| 66 | MP0005397_hematopoietic_system_phenotyp | 1.24826455 |
| 67 | MP0001545_abnormal_hematopoietic_system | 1.24826455 |
| 68 | MP0003950_abnormal_plasma_membrane | 1.23578352 |
| 69 | MP0005075_abnormal_melanosome_morpholog | 1.23578294 |
| 70 | MP0009840_abnormal_foam_cell | 1.21429720 |
| 71 | MP0000490_abnormal_crypts_of | 1.21286375 |
| 72 | MP0001529_abnormal_vocalization | 1.20503221 |
| 73 | MP0001986_abnormal_taste_sensitivity | 1.20479074 |
| 74 | MP0001542_abnormal_bone_strength | 1.19577171 |
| 75 | MP0008007_abnormal_cellular_replicative | 1.19542988 |
| 76 | MP0002163_abnormal_gland_morphology | 1.18093001 |
| 77 | MP0000681_abnormal_thyroid_gland | 1.17831808 |
| 78 | MP0002837_dystrophic_cardiac_calcinosis | 1.17445437 |
| 79 | MP0005165_increased_susceptibility_to | 1.15686872 |
| 80 | MP0005408_hypopigmentation | 1.14708955 |
| 81 | MP0000703_abnormal_thymus_morphology | 1.13854119 |
| 82 | MP0010155_abnormal_intestine_physiology | 1.12914801 |
| 83 | MP0003172_abnormal_lysosome_physiology | 1.11417723 |
| 84 | MP0002938_white_spotting | 1.10937713 |
| 85 | MP0001958_emphysema | 1.08594849 |
| 86 | MP0005409_darkened_coat_color | 1.06316982 |
| 87 | MP0009697_abnormal_copulation | 1.05917018 |
| 88 | MP0001764_abnormal_homeostasis | 1.05249660 |
| 89 | MP0010234_abnormal_vibrissa_follicle | 1.04981735 |
| 90 | MP0002090_abnormal_vision | 1.01380984 |
| 91 | MP0002638_abnormal_pupillary_reflex | 1.01009280 |
| 92 | MP0005390_skeleton_phenotype | 0.98867995 |
| 93 | MP0005164_abnormal_response_to | 0.97834527 |
| 94 | MP0004510_myositis | 0.97302501 |
| 95 | MP0008058_abnormal_DNA_repair | 0.96281020 |
| 96 | MP0008469_abnormal_protein_level | 0.96105410 |
| 97 | MP0009763_increased_sensitivity_to | 0.94684662 |
| 98 | MP0003448_altered_tumor_morphology | 0.94436680 |
| 99 | MP0003866_abnormal_defecation | 0.93214674 |
| 100 | MP0010352_gastrointestinal_tract_polyps | 0.93056997 |
| 101 | MP0005319_abnormal_enzyme/_coenzyme | 0.92736288 |
| 102 | MP0000604_amyloidosis | 0.91268724 |
| 103 | MP0005084_abnormal_gallbladder_morpholo | 0.89783114 |
| 104 | MP0005085_abnormal_gallbladder_physiolo | 0.89417664 |
| 105 | MP0004947_skin_inflammation | 0.89046443 |
| 106 | MP0002332_abnormal_exercise_endurance | 0.86463001 |
| 107 | MP0000569_abnormal_digit_pigmentation | 0.84800304 |
| 108 | MP0010094_abnormal_chromosome_stability | 0.84004147 |
| 109 | MP0002132_abnormal_respiratory_system | 0.83496192 |
| 110 | MP0003186_abnormal_redox_activity | 0.83024301 |
| 111 | MP0005376_homeostasis/metabolism_phenot | 0.82874325 |
| 112 | MP0002998_abnormal_bone_remodeling | 0.81923776 |
| 113 | MP0000920_abnormal_myelination | 0.80483509 |
| 114 | MP0002295_abnormal_pulmonary_circulatio | 0.80458026 |
| 115 | MP0002736_abnormal_nociception_after | 0.79893230 |
| 116 | MP0005023_abnormal_wound_healing | 0.79680420 |
| 117 | MP0004134_abnormal_chest_morphology | 0.79116408 |
| 118 | MP0004883_abnormal_blood_vessel | 0.78657308 |
| 119 | MP0006276_abnormal_autonomic_nervous | 0.78063124 |
| 120 | MP0003011_delayed_dark_adaptation | 0.76040923 |
| 121 | MP0005310_abnormal_salivary_gland | 0.75440914 |
| 122 | MP0005379_endocrine/exocrine_gland_phen | 0.72600368 |
| 123 | MP0002019_abnormal_tumor_incidence | 0.71673345 |
| 124 | MP0003795_abnormal_bone_structure | 0.71215119 |
| 125 | MP0005365_abnormal_bile_salt | 0.70921561 |
| 126 | MP0003075_altered_response_to | 0.70497417 |
| 127 | MP0006035_abnormal_mitochondrial_morpho | 0.70096797 |
| 128 | MP0001243_abnormal_dermal_layer | 0.69331859 |
| 129 | MP0001968_abnormal_touch/_nociception | 0.69299724 |
| 130 | MP0002693_abnormal_pancreas_physiology | 0.68894659 |
| 131 | MP0001873_stomach_inflammation | 0.68650736 |
| 132 | MP0003077_abnormal_cell_cycle | 0.66261005 |
| 133 | MP0009764_decreased_sensitivity_to | 0.64622751 |
| 134 | MP0004957_abnormal_blastocyst_morpholog | 0.63071154 |
| 135 | MP0002735_abnormal_chemical_nociception | 0.61768614 |
| 136 | MP0010386_abnormal_urinary_bladder | 0.60894338 |
| 137 | MP0005058_abnormal_lysosome_morphology | 0.59788093 |
| 138 | MP0004142_abnormal_muscle_tone | 0.59663379 |
| 139 | MP0005171_absent_coat_pigmentation | 0.57712797 |
| 140 | MP0008873_increased_physiological_sensi | 0.57338179 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.45251350 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.32970850 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.32324064 |
| 4 | Abnormality of glycolipid metabolism (HP:0010969) | 4.29741107 |
| 5 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.29741107 |
| 6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.29741107 |
| 7 | Abnormal number of erythroid precursors (HP:0012131) | 4.26179331 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 3.79711796 |
| 9 | Increased hepatocellular lipid droplets (HP:0006565) | 3.52787978 |
| 10 | Mitochondrial inheritance (HP:0001427) | 3.43032078 |
| 11 | Exertional dyspnea (HP:0002875) | 3.40391516 |
| 12 | Reticulocytopenia (HP:0001896) | 3.36228271 |
| 13 | Myositis (HP:0100614) | 3.36048860 |
| 14 | Thrombocytosis (HP:0001894) | 3.33669839 |
| 15 | Acute necrotizing encephalopathy (HP:0006965) | 3.32898562 |
| 16 | Type I transferrin isoform profile (HP:0003642) | 3.27243757 |
| 17 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.22406117 |
| 18 | Loss of speech (HP:0002371) | 3.20917419 |
| 19 | Aplastic anemia (HP:0001915) | 3.08243999 |
| 20 | IgM deficiency (HP:0002850) | 3.04927809 |
| 21 | Disinhibition (HP:0000734) | 3.04377451 |
| 22 | Hepatosplenomegaly (HP:0001433) | 2.99231514 |
| 23 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.96486679 |
| 24 | Renal Fanconi syndrome (HP:0001994) | 2.94950251 |
| 25 | 3-Methylglutaconic aciduria (HP:0003535) | 2.92549249 |
| 26 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.92296730 |
| 27 | Hepatocellular necrosis (HP:0001404) | 2.91568300 |
| 28 | Pallor (HP:0000980) | 2.91462007 |
| 29 | Progressive neurologic deterioration (HP:0002344) | 2.85816783 |
| 30 | Chronic obstructive pulmonary disease (HP:0006510) | 2.81969462 |
| 31 | Obstructive lung disease (HP:0006536) | 2.81969462 |
| 32 | Lipid accumulation in hepatocytes (HP:0006561) | 2.79519635 |
| 33 | Petechiae (HP:0000967) | 2.77033103 |
| 34 | Eczematoid dermatitis (HP:0000976) | 2.76528081 |
| 35 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.76326626 |
| 36 | Progressive macrocephaly (HP:0004481) | 2.73880211 |
| 37 | Increased CSF lactate (HP:0002490) | 2.70530766 |
| 38 | Mediastinal lymphadenopathy (HP:0100721) | 2.67973870 |
| 39 | Chronic otitis media (HP:0000389) | 2.66345190 |
| 40 | Abnormal protein glycosylation (HP:0012346) | 2.65545633 |
| 41 | Abnormal glycosylation (HP:0012345) | 2.65545633 |
| 42 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.65545633 |
| 43 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.65545633 |
| 44 | Systemic lupus erythematosus (HP:0002725) | 2.62797321 |
| 45 | Poor head control (HP:0002421) | 2.62102315 |
| 46 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.61408030 |
| 47 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.61408030 |
| 48 | Recurrent skin infections (HP:0001581) | 2.60794262 |
| 49 | Meningitis (HP:0001287) | 2.59959063 |
| 50 | Macrocytic anemia (HP:0001972) | 2.57569338 |
| 51 | Axonal loss (HP:0003447) | 2.55391857 |
| 52 | Nausea (HP:0002018) | 2.53185121 |
| 53 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.53088254 |
| 54 | Reduced antithrombin III activity (HP:0001976) | 2.50477954 |
| 55 | Vertebral compression fractures (HP:0002953) | 2.49845997 |
| 56 | Keratoconjunctivitis sicca (HP:0001097) | 2.45408512 |
| 57 | Anorexia (HP:0002039) | 2.45348142 |
| 58 | Abnormality of methionine metabolism (HP:0010901) | 2.42378872 |
| 59 | Panhypogammaglobulinemia (HP:0003139) | 2.41674301 |
| 60 | Tetraparesis (HP:0002273) | 2.41627771 |
| 61 | Recurrent bronchitis (HP:0002837) | 2.41183982 |
| 62 | Cerebral edema (HP:0002181) | 2.39754112 |
| 63 | Increased cerebral lipofuscin (HP:0011813) | 2.39333059 |
| 64 | Recurrent pneumonia (HP:0006532) | 2.37872051 |
| 65 | Hypothermia (HP:0002045) | 2.36490065 |
| 66 | Vacuolated lymphocytes (HP:0001922) | 2.35480804 |
| 67 | Agammaglobulinemia (HP:0004432) | 2.33468887 |
| 68 | Mutism (HP:0002300) | 2.33246856 |
| 69 | Increased intramyocellular lipid droplets (HP:0012240) | 2.32416341 |
| 70 | Keratoconjunctivitis (HP:0001096) | 2.31786172 |
| 71 | Recurrent lower respiratory tract infections (HP:0002783) | 2.29235283 |
| 72 | Cellulitis (HP:0100658) | 2.23557799 |
| 73 | Retrobulbar optic neuritis (HP:0100654) | 2.22806121 |
| 74 | Optic neuritis (HP:0100653) | 2.22806121 |
| 75 | Patchy hypopigmentation of hair (HP:0011365) | 2.22527989 |
| 76 | Respiratory failure (HP:0002878) | 2.21089027 |
| 77 | Hepatic necrosis (HP:0002605) | 2.21048874 |
| 78 | Vasculitis (HP:0002633) | 2.20975291 |
| 79 | Palpitations (HP:0001962) | 2.20935819 |
| 80 | Conjunctival hamartoma (HP:0100780) | 2.18960404 |
| 81 | Urticaria (HP:0001025) | 2.18321602 |
| 82 | Respiratory difficulties (HP:0002880) | 2.18148486 |
| 83 | Bone cyst (HP:0012062) | 2.17880943 |
| 84 | IgG deficiency (HP:0004315) | 2.16190780 |
| 85 | Nuclear cataract (HP:0100018) | 2.14673406 |
| 86 | Myocardial infarction (HP:0001658) | 2.12527768 |
| 87 | Acute encephalopathy (HP:0006846) | 2.11954095 |
| 88 | Recurrent viral infections (HP:0004429) | 2.11895296 |
| 89 | Generalized aminoaciduria (HP:0002909) | 2.10750142 |
| 90 | Congenital, generalized hypertrichosis (HP:0004540) | 2.10601779 |
| 91 | Dysostosis multiplex (HP:0000943) | 2.10218961 |
| 92 | Orchitis (HP:0100796) | 2.08877992 |
| 93 | Syringomyelia (HP:0003396) | 2.08176076 |
| 94 | Spinal cord lesions (HP:0100561) | 2.08176076 |
| 95 | Abnormality of T cell physiology (HP:0011840) | 2.07814551 |
| 96 | Abnormality of macrophages (HP:0004311) | 2.07096256 |
| 97 | Basal ganglia calcification (HP:0002135) | 2.05544089 |
| 98 | Recurrent fungal infections (HP:0002841) | 2.05493418 |
| 99 | Parakeratosis (HP:0001036) | 2.05214102 |
| 100 | Amyloidosis (HP:0011034) | 2.05131802 |
| 101 | Stomatitis (HP:0010280) | 2.04763917 |
| 102 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.03965909 |
| 103 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.01892804 |
| 104 | Recurrent cutaneous fungal infections (HP:0011370) | 2.01892804 |
| 105 | Hematochezia (HP:0002573) | 1.99663374 |
| 106 | Heterochromia iridis (HP:0001100) | 1.99406706 |
| 107 | Papilledema (HP:0001085) | 1.98275842 |
| 108 | Increased CSF protein (HP:0002922) | 1.97727288 |
| 109 | Encephalitis (HP:0002383) | 1.96505114 |
| 110 | Abnormality of B cell number (HP:0010975) | 1.95443917 |
| 111 | B lymphocytopenia (HP:0010976) | 1.95443917 |
| 112 | Exercise intolerance (HP:0003546) | 1.94430355 |
| 113 | Episodic fever (HP:0001954) | 1.94310790 |
| 114 | Chronic sinusitis (HP:0011109) | 1.92705768 |
| 115 | Abnormality of the prostate (HP:0008775) | 1.92151715 |
| 116 | Mucosal telangiectasiae (HP:0100579) | 1.91383227 |
| 117 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.90806839 |
| 118 | Gastrointestinal stroma tumor (HP:0100723) | 1.90367973 |
| 119 | Pulmonary fibrosis (HP:0002206) | 1.90073723 |
| 120 | Pulmonary infiltrates (HP:0002113) | 1.89210198 |
| 121 | Muscle fibrillation (HP:0010546) | 1.87757765 |
| 122 | Hypergammaglobulinemia (HP:0010702) | 1.86549555 |
| 123 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.85861879 |
| 124 | Gastrointestinal infarctions (HP:0005244) | 1.83869147 |
| 125 | White forelock (HP:0002211) | 1.82605248 |
| 126 | Beaking of vertebral bodies (HP:0004568) | 1.82583453 |
| 127 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.82224064 |
| 128 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.81711159 |
| 129 | Lymphopenia (HP:0001888) | 1.81158723 |
| 130 | Retinal dysplasia (HP:0007973) | 1.80010355 |
| 131 | Osteolytic defects of the hand bones (HP:0009699) | 1.79816153 |
| 132 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.79816153 |
| 133 | Increased IgM level (HP:0003496) | 1.77729529 |
| 134 | Abnormality of the basal ganglia (HP:0002134) | 1.77555113 |
| 135 | Gangrene (HP:0100758) | 1.76588084 |
| 136 | Lactic acidosis (HP:0003128) | 1.75717953 |
| 137 | Increased serum lactate (HP:0002151) | 1.75079349 |
| 138 | Abnormality of renal resorption (HP:0011038) | 1.74998923 |
| 139 | Agnosia (HP:0010524) | 1.73655915 |
| 140 | Peritonitis (HP:0002586) | 1.73323806 |
| 141 | Purpura (HP:0000979) | 1.72442050 |
| 142 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.71871579 |
| 143 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.71871579 |
| 144 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.71871579 |
| 145 | Polyneuropathy (HP:0001271) | 1.71779627 |
| 146 | Optic disc pallor (HP:0000543) | 1.71272619 |
| 147 | Vascular calcification (HP:0004934) | 1.70352147 |
| 148 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.70139526 |
| 149 | Thyroiditis (HP:0100646) | 1.70071913 |
| 150 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.69600576 |
| 151 | Joint stiffness (HP:0001387) | 1.68892294 |
| 152 | Leukocytosis (HP:0001974) | 1.68573277 |
| 153 | Hemoptysis (HP:0002105) | 1.68562696 |
| 154 | Abnormality of the anterior horn cell (HP:0006802) | 1.68365215 |
| 155 | Degeneration of anterior horn cells (HP:0002398) | 1.68365215 |
| 156 | Severe combined immunodeficiency (HP:0004430) | 1.68156913 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 3.99177871 |
| 2 | STK16 | 3.29496105 |
| 3 | PIM2 | 2.93056458 |
| 4 | MAP3K12 | 2.90458853 |
| 5 | BLK | 2.44421147 |
| 6 | VRK1 | 2.36475143 |
| 7 | IRAK4 | 2.22389345 |
| 8 | VRK2 | 2.22317124 |
| 9 | RIPK4 | 2.21649326 |
| 10 | KIT | 2.17004183 |
| 11 | TEC | 2.06746325 |
| 12 | CDK19 | 2.04407486 |
| 13 | MAP4K1 | 2.02636829 |
| 14 | PAK4 | 1.99381740 |
| 15 | LIMK1 | 1.96465442 |
| 16 | MAP3K3 | 1.87307637 |
| 17 | EIF2AK3 | 1.87082248 |
| 18 | EIF2AK1 | 1.86666648 |
| 19 | TNIK | 1.86023869 |
| 20 | TXK | 1.79696988 |
| 21 | TRIM28 | 1.79508228 |
| 22 | TESK1 | 1.66727413 |
| 23 | CSF1R | 1.65420670 |
| 24 | FES | 1.63730593 |
| 25 | ARAF | 1.63480367 |
| 26 | TESK2 | 1.58828331 |
| 27 | SYK | 1.49563277 |
| 28 | ERBB3 | 1.43279708 |
| 29 | BTK | 1.42289278 |
| 30 | STK10 | 1.41372531 |
| 31 | BMPR2 | 1.32878843 |
| 32 | PBK | 1.30082946 |
| 33 | BUB1 | 1.28167212 |
| 34 | MKNK1 | 1.26802159 |
| 35 | LYN | 1.21443954 |
| 36 | TBK1 | 1.18527596 |
| 37 | GRK7 | 1.17119737 |
| 38 | DYRK2 | 1.17114965 |
| 39 | JAK3 | 1.16538931 |
| 40 | ZAP70 | 1.12965746 |
| 41 | IKBKB | 1.11880864 |
| 42 | TAOK1 | 1.11662295 |
| 43 | IRAK2 | 1.09928263 |
| 44 | MAPK13 | 1.09861540 |
| 45 | CASK | 1.07516870 |
| 46 | RPS6KA4 | 1.05641293 |
| 47 | MYLK | 1.04955392 |
| 48 | NEK1 | 1.04470474 |
| 49 | MAP3K14 | 1.02253563 |
| 50 | TGFBR1 | 1.02224480 |
| 51 | TLK1 | 1.01376375 |
| 52 | ADRBK2 | 1.00082669 |
| 53 | TYK2 | 0.99277412 |
| 54 | TGFBR2 | 0.99252097 |
| 55 | EIF2AK2 | 0.95260257 |
| 56 | SIK3 | 0.94084905 |
| 57 | PRKG2 | 0.94082733 |
| 58 | BMPR1B | 0.93996994 |
| 59 | CLK1 | 0.93671519 |
| 60 | PLK3 | 0.92856320 |
| 61 | CDK8 | 0.91877523 |
| 62 | NME1 | 0.89033454 |
| 63 | LCK | 0.87063162 |
| 64 | NUAK1 | 0.86810466 |
| 65 | GRK1 | 0.84826733 |
| 66 | DAPK1 | 0.84646702 |
| 67 | IKBKE | 0.84571864 |
| 68 | MUSK | 0.84507477 |
| 69 | MAP3K5 | 0.83745074 |
| 70 | CAMKK2 | 0.83700132 |
| 71 | STK4 | 0.82998547 |
| 72 | MAPKAPK5 | 0.80249524 |
| 73 | KDR | 0.80153738 |
| 74 | PIK3CG | 0.77291329 |
| 75 | CSNK1G3 | 0.77069699 |
| 76 | MAP2K6 | 0.76959764 |
| 77 | YES1 | 0.75963611 |
| 78 | ABL2 | 0.75575147 |
| 79 | IRAK1 | 0.73608327 |
| 80 | MAP3K2 | 0.72933230 |
| 81 | MAP2K7 | 0.72921472 |
| 82 | ILK | 0.72444937 |
| 83 | MST4 | 0.70399386 |
| 84 | PLK2 | 0.70182341 |
| 85 | WEE1 | 0.68834111 |
| 86 | LRRK2 | 0.68182717 |
| 87 | CCNB1 | 0.66427554 |
| 88 | MOS | 0.66364325 |
| 89 | STK24 | 0.65689979 |
| 90 | JAK2 | 0.65192623 |
| 91 | TRPM7 | 0.63551978 |
| 92 | IRAK3 | 0.63437951 |
| 93 | PDK2 | 0.62731131 |
| 94 | MAP4K2 | 0.62576262 |
| 95 | ERBB4 | 0.62055959 |
| 96 | MAP3K1 | 0.61911655 |
| 97 | DYRK3 | 0.61702674 |
| 98 | ACVR1B | 0.61384684 |
| 99 | MARK1 | 0.61380257 |
| 100 | FGR | 0.59427564 |
| 101 | TAF1 | 0.58716286 |
| 102 | MATK | 0.58640791 |
| 103 | JAK1 | 0.58478330 |
| 104 | HCK | 0.57674438 |
| 105 | MAP3K11 | 0.57232595 |
| 106 | DDR2 | 0.56472779 |
| 107 | SCYL2 | 0.54926677 |
| 108 | ITK | 0.54625754 |
| 109 | FLT3 | 0.54194740 |
| 110 | MAPK4 | 0.54043072 |
| 111 | BRSK2 | 0.53681905 |
| 112 | RAF1 | 0.53386589 |
| 113 | ROCK2 | 0.52861414 |
| 114 | CSK | 0.52255672 |
| 115 | RPS6KA5 | 0.48766956 |
| 116 | TAOK2 | 0.48367729 |
| 117 | PRKCD | 0.48040828 |
| 118 | MAP3K13 | 0.47246257 |
| 119 | TNK2 | 0.47135021 |
| 120 | BCKDK | 0.46818946 |
| 121 | MKNK2 | 0.46164189 |
| 122 | ADRBK1 | 0.44935803 |
| 123 | SRPK1 | 0.43575277 |
| 124 | STK3 | 0.43428056 |
| 125 | PIM1 | 0.43350325 |
| 126 | OXSR1 | 0.41382521 |
| 127 | MAP2K3 | 0.40134471 |
| 128 | MAP3K8 | 0.40112291 |
| 129 | PASK | 0.39735719 |
| 130 | CDK6 | 0.39488062 |
| 131 | MINK1 | 0.38496773 |
| 132 | PTK2B | 0.38221138 |
| 133 | CSNK2A1 | 0.37461798 |
| 134 | DAPK3 | 0.37205454 |
| 135 | CDK14 | 0.36930682 |
| 136 | EPHB1 | 0.36452838 |
| 137 | ABL1 | 0.35319479 |
| 138 | NEK9 | 0.35273444 |
| 139 | LMTK2 | 0.34898242 |
| 140 | FER | 0.34777653 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.31690614 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.40697874 |
| 3 | Protein export_Homo sapiens_hsa03060 | 2.73418729 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 2.64227832 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.34556012 |
| 6 | RNA polymerase_Homo sapiens_hsa03020 | 2.28955310 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.28092349 |
| 8 | Parkinsons disease_Homo sapiens_hsa05012 | 2.14037848 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.13456571 |
| 10 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.07984696 |
| 11 | Mismatch repair_Homo sapiens_hsa03430 | 2.03930618 |
| 12 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.00631671 |
| 13 | Base excision repair_Homo sapiens_hsa03410 | 1.77431186 |
| 14 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.74172100 |
| 15 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.73396904 |
| 16 | Alzheimers disease_Homo sapiens_hsa05010 | 1.64128875 |
| 17 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.62909078 |
| 18 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.60865008 |
| 19 | Spliceosome_Homo sapiens_hsa03040 | 1.60765230 |
| 20 | Homologous recombination_Homo sapiens_hsa03440 | 1.58124210 |
| 21 | Allograft rejection_Homo sapiens_hsa05330 | 1.53718418 |
| 22 | Huntingtons disease_Homo sapiens_hsa05016 | 1.52360331 |
| 23 | Leishmaniasis_Homo sapiens_hsa05140 | 1.51357112 |
| 24 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.48370771 |
| 25 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.45472827 |
| 26 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.45201193 |
| 27 | Shigellosis_Homo sapiens_hsa05131 | 1.43759942 |
| 28 | Pertussis_Homo sapiens_hsa05133 | 1.36281476 |
| 29 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.33990605 |
| 30 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.30907916 |
| 31 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.29786316 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.25958954 |
| 33 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.24089127 |
| 34 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.24063570 |
| 35 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.21636660 |
| 36 | Legionellosis_Homo sapiens_hsa05134 | 1.20411397 |
| 37 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.19816054 |
| 38 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.17598565 |
| 39 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.16988677 |
| 40 | Asthma_Homo sapiens_hsa05310 | 1.15838626 |
| 41 | Other glycan degradation_Homo sapiens_hsa00511 | 1.15788229 |
| 42 | Malaria_Homo sapiens_hsa05144 | 1.15589897 |
| 43 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.10760843 |
| 44 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.09652284 |
| 45 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.08671011 |
| 46 | Measles_Homo sapiens_hsa05162 | 1.08414308 |
| 47 | Phagosome_Homo sapiens_hsa04145 | 1.05865867 |
| 48 | Salmonella infection_Homo sapiens_hsa05132 | 1.03011354 |
| 49 | Basal transcription factors_Homo sapiens_hsa03022 | 1.01346523 |
| 50 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.99360669 |
| 51 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.97499469 |
| 52 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.96698101 |
| 53 | Tuberculosis_Homo sapiens_hsa05152 | 0.96474102 |
| 54 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.93406171 |
| 55 | Galactose metabolism_Homo sapiens_hsa00052 | 0.92969387 |
| 56 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.92965261 |
| 57 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.92921652 |
| 58 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.92909610 |
| 59 | Viral myocarditis_Homo sapiens_hsa05416 | 0.92357752 |
| 60 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.90569693 |
| 61 | Purine metabolism_Homo sapiens_hsa00230 | 0.88828695 |
| 62 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.88602765 |
| 63 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.87823342 |
| 64 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.86050715 |
| 65 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.84301038 |
| 66 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.83414155 |
| 67 | RNA degradation_Homo sapiens_hsa03018 | 0.80649536 |
| 68 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.79368350 |
| 69 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.78368231 |
| 70 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.74622981 |
| 71 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.74325824 |
| 72 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.72358651 |
| 73 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.72037823 |
| 74 | Hepatitis B_Homo sapiens_hsa05161 | 0.69687040 |
| 75 | Apoptosis_Homo sapiens_hsa04210 | 0.69420484 |
| 76 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.69359916 |
| 77 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.68855485 |
| 78 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.68137419 |
| 79 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.67539481 |
| 80 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.66722927 |
| 81 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.66181479 |
| 82 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.65398697 |
| 83 | Mineral absorption_Homo sapiens_hsa04978 | 0.63044347 |
| 84 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.62802335 |
| 85 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.62640927 |
| 86 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.60767067 |
| 87 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.59741218 |
| 88 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58955475 |
| 89 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.57278890 |
| 90 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.57277569 |
| 91 | Lysosome_Homo sapiens_hsa04142 | 0.56764819 |
| 92 | Cell cycle_Homo sapiens_hsa04110 | 0.55704470 |
| 93 | RNA transport_Homo sapiens_hsa03013 | 0.55541551 |
| 94 | Peroxisome_Homo sapiens_hsa04146 | 0.55455485 |
| 95 | Influenza A_Homo sapiens_hsa05164 | 0.52944053 |
| 96 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.52521753 |
| 97 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.51856668 |
| 98 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.50683799 |
| 99 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.50520924 |
| 100 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.50499640 |
| 101 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.49899539 |
| 102 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.48086253 |
| 103 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.46832266 |
| 104 | Platelet activation_Homo sapiens_hsa04611 | 0.46000874 |
| 105 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.45992853 |
| 106 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.45522734 |
| 107 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.44497745 |
| 108 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.43766746 |
| 109 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.43583239 |
| 110 | * Alcoholism_Homo sapiens_hsa05034 | 0.42573832 |
| 111 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.40651375 |
| 112 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40354664 |
| 113 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.40221827 |
| 114 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.39276297 |
| 115 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.38577354 |
| 116 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.38566935 |
| 117 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.37981677 |
| 118 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.37521593 |
| 119 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.36872009 |
| 120 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.36289960 |
| 121 | Hepatitis C_Homo sapiens_hsa05160 | 0.36222951 |
| 122 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.35274654 |
| 123 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.35129476 |
| 124 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.33895368 |
| 125 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.31313309 |
| 126 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.31237911 |
| 127 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.30842289 |
| 128 | Endocytosis_Homo sapiens_hsa04144 | 0.30444573 |

